Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Randal W. Scott,PhDN/A1,185,1173.59%2012-07-10
Steven Shak,M.D.Chief Scientific Officer327,2070.99%2016-06-21
Joffre B. Baker,PhDN/A132,8460.4%2012-02-15
Dr. Fred E. Cohen,M.D.,D.Phil.N/A64,8930.2%2016-07-01
Kimberly J. PopovitsN/A58,7960.18%2016-02-15
G. Bradley ColeCOO35,4260.11%2016-06-09
Mr. James J. VaughnChief Commercial Officer32,0790.1%2016-06-06
Mr. Frederic PlaN/A25,618less than 0.1%2016-02-15
Mr. Dean L. SchornoN/A24,524less than 0.1%2014-06-10
Brook H. ByersN/A23,951less than 0.1%2010-12-09

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.12.84327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.25.8635,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.859.43327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.15.9435,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.920.7132,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.61382.1734,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.013.6815,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$28560.7131,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.310.89326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.080.7124,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-12.266,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-11.0127,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-16.1524,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-3.6227,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-3.8512,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-3.8524,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.128.3430,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.9811.2430,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.122.4330,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.967.4730,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.162.429,658 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-04-13Sell3,000203,001$31.2893.84-9.85Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-7.3629,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-11.63Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-11.4329,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-5.56Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-10.1121,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-11.686,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-15.72Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-14.52Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-13.2821,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-19.01Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-20.2322,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-22.196,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-8.38Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.08-1.9822,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-5.43Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-6.2822,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.23.07312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.218.17Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.776.05Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.224.2522,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271894.44312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.115.5312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.38.05Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.482.124,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.783.3322,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.626.25Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.3612.423,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.757.43311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27814.4422,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.52-0.56311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.281.5922,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.581.1515,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.662.99311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27814.4424,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-10.5308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-6Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.510.1118,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-4.63308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-8.08Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-15.1921,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-19.246,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-18.45Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-15.4721,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-10.1318,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-4.95308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-6Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-5.8418,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-16.39313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-17.81Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-13.3118,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-14.2921,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-10.456,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-14.49318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-14.62Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-14.9321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-14.9321,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-16.2219,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-20.18318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-18.52Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-16.5917,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-16.5917,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-15.3913,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-15.87323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-20.96Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-21.417,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-22.01
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-22.6813,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-23.18
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-22.536,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-23.56
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-23.64
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-24.767,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-24.17327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-22.63
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-21.36,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-17.88
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-18.077,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-18.73Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-21.7117,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-21.6412,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-6Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.481.4812,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.43-1.312,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.581.51
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.40.257,087 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.96-0.98
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.5-0.72,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.530.18
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.080.6114,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.54-1.986,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.50.7117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.71.1514,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.71.66333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.951.48Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$28840.7117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.681.296,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.125.11288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.264.8736,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.74.68338,768 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.523.22288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.23.52Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.11.4288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$28840.7117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.55-1.4714,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-14.75Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-20343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-16.5417,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-16.5211,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-18.9714,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-16.47348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-11.01Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-19.4514,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-19.892,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-19.41353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-18.78Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-7.5114,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-21.456,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-17.64358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-18.87Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-20.32Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-21.5614,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-15.19363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-15.47Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-15.47Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-15.92Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-16.9913,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-16.57367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-12.59
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-14.6226,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-16.77
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-17.62Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-16.317,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-5.87
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-6.68Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.18-2.3213,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.69-0.88
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.42-0.046,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.650.97372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.951.48Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.980.7918,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.8-1.36Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-6.8713,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-6.25377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-6.22Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-6.22Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-6.25377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-9.2719,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-9.18Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-5.8113,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-6.34
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-6.34
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-6.34
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-5.4
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-5.4
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-5.4
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.19-2.96
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-2.96
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.71-2.96
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.5285-1.05Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.380.5
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.80.5
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.10.5
1,419,381 (Through Partnership)
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.70.21382,849 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-3.89
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-3.98
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-3.98
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.71-1.9520,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.76-1.9520,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.246.98
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.096.98
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.136.98
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.67.72Link
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.67.72Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.186.5414,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.022.516,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.16.74Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.15.94Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.75.46382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$28280.7117,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.852.47,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.22.69Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.158.34387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.83.33Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.48-1.367,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.630.28
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.721.95
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.160.28
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.318.84
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.168.71
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.788.84
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.358.17392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.981.77
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.661.77
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.533.11
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.193.56
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.483.56
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.83.52Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.525.26
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.56.027,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.748.71
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.498.71
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9415.2
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1627.726,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.829.6392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.623.52Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5526.47,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.235.51Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.227.727,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.122.5392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.815.38Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1511.647,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1511.647,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.96.626,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.052.14392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.23.071,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.71.667,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.63.98392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.918.8418,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.89.771,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.127.67
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.927.67
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.687.63
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.457.727,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.613.15
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.063.11
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.33.11
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.7510.37392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.486.519,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.25.78Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.838.757,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.088.29Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.911.11Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.9210.63Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.3211.37Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.28.63Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.554.79Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2515.34Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7918.54Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3216.1Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3216.1Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.410.07Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.388.34Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7812.53Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1212.53Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.0811.77Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.4410.81Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.069.77Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.79.77Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9220.56Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2120.56Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3521.19Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5125.28Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0825.28Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244427.03Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.233.33Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.233.33Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8733.9Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.629.77Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6527.43Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6824.17Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.225.56Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.624.56Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514061.14Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.156.32Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.454.35Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.95279102.15Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7886.75Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.489.64Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5387.87Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1590.41Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9290.41Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.6495.02Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.1395.02Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.0796.24Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.7396.24Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.8194.21Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.394.21Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9488.13Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6188.13Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5687.13Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4289.9Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7689.9Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.588Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.291.71Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.5893.02Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.2393.02Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2891.19Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2120.14Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41116.09Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.1528399.29Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.04100.71Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2478.71Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6877.69Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.280.65Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.881.82Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.467.16Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.566.86Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1467.06Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538944.99Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338646.11Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4845.44Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3244.99Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7942.21Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1565.4Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7965.4Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.663.67Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7861.05Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5265.78Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9465.78Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3464.53Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2563.48Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8761.42Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.640.16Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9538.3Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8438.1Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8839.33Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7839.19Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.246.8Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3340.72Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8841.07Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5841Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2536.56Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.138.1Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9236.5Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179833.21Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6533.46Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6536.03Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0436.43Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1440.16Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8535.77Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7441.14Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2741.14Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6841.14Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9141.14Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6544.39Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010041Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4444.69Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8844.62Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.844.69Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8844.69Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0445.21Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1744.76Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1176.14
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1176.14
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6254.35
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8959.41
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199548.42
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9156.93
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6256.93
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8156.93
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4556.93
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.640.16
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5244.91
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7244.25
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.144.25
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4644.25
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8244.25
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2843
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.6410.72
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.9711.59
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.845.36
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5547.41
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.631.04
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3636.89
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3636.89
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.235.25
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8545.29
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0239.81
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1146.49
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1146.49
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.853.26
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9841.92
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9841.92
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.640.65
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.739.81
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3238.51
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.425.28
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3524.39
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4829.42
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6522.98
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0324.28
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0819.14
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460616.34
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1218.69
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125234.29
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1546.42
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20241
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0441.57
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7741.64
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4641.64
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0541.64
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2856.75
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522550.4
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.246.34
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6463.76
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0849.68
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.837.7
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1539.4
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2224.89
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1222.56
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1922.93
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.4810.42
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8924.45
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9322.08
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4128.18
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8422.24
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4421.5
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9239.88
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8442.14
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2843.22
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.443.15
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5944.1
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3750.32
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9241.64
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9945.06
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1633.14
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018848.34
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9247.18
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2960.59
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8972.79
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8772.79
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.172.79
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0972.79
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7769.98
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6669.98
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.969.98
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6269.98
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9581.94
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6181.94
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0281.94
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.681.94
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8481.94
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9581.94
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4469.68
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.572.9
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2463.29
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4364.34
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1554.27
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8754.27
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.354.27
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2854.27
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2654.27
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.253.68
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1555.89
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8855.89
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.455.8
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0955.89
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4155.89
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1655.12
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2643.66
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1452.1
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.252.1
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7352.1
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0452.1
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0452.1
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5754.52
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5654.52
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0454.52
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6754.52
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5554.52
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4455.63
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8148.66
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8530.68
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4530.68
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1730.68
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0730.68
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.728.36
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3836.89
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8836.89
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1336.89
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2636.89
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.72100.71Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.21100.71Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.17100.71Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79135Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21135Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK